Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with complex biology and significant clinical heterogeneity. Many preclinical and early phase ALS clinical trials have yielded promising results that could not be replicated in larger phase 3 confirmatory trials. One re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Muscle Nerve
Asıl Yazarlar: Goyal, Namita A., Berry, James D., Windebank, Anthony, Staff, Nathan P., Maragakis, Nicholas J., van den Berg, Leonard H., Genge, Angela, Miller, Robert, Baloh, Robert H., Kern, Ralph, Gothelf, Yael, Lebovits, Chaim, Cudkowicz, Merit
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
Invited Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496557/
https://ncbi.nlm.nih.gov/pubmed/31899540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26801
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller